168 related articles for article (PubMed ID: 37098141)
1. Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.
Raza S; Rudolph JL; Mujahid N; Neupane I; Monteiro JFG; Singh M; Khurshid H
R I Med J (2013); 2023 May; 106(4):13-18. PubMed ID: 37098141
[TBL] [Abstract][Full Text] [Related]
2. Development of a comprehensive multidisciplinary geriatric oncology center, the Thomas Jefferson University Experience.
Chapman AE; Swartz K; Schoppe J; Arenson C
J Geriatr Oncol; 2014 Apr; 5(2):164-70. PubMed ID: 24495585
[TBL] [Abstract][Full Text] [Related]
3. Use of comprehensive geriatric assessment (CGA) to define frailty in geriatric oncology: Searching for the best threshold. Cross-sectional study of 418 old patients with cancer evaluated in the Geriatric Frailty Clinic (G.F.C.) of Toulouse (France).
Bréchemier D; Sourdet S; Girard P; Steinmeyer Z; Mourey L; Gérard S; Balardy L
J Geriatr Oncol; 2019 Nov; 10(6):944-950. PubMed ID: 30956134
[TBL] [Abstract][Full Text] [Related]
4. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
[TBL] [Abstract][Full Text] [Related]
5. A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in Older Adults with Cancer: Development and Construct Validation.
Nishijima TF; Shimokawa M; Esaki T; Morita M; Toh Y; Muss HB
Oncologist; 2021 Oct; 26(10):e1751-e1760. PubMed ID: 34216413
[TBL] [Abstract][Full Text] [Related]
6. [A comparative study of comprehensive geriatric assessment in elder patients with non-Hodgkin's lymphoma].
Liu H; Gao M; Mei D; Han HX; Li JT; Bai JF; Zhang CL; Feng R; Wei JP; Tian Y; Wang T
Zhonghua Nei Ke Za Zhi; 2018 May; 57(5):330-334. PubMed ID: 29747287
[No Abstract] [Full Text] [Related]
7. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
8. Association of frailty with chemotherapy toxicity in chemotherapy-naive older patients with cancer.
Akbıyık I; Yüce D; Kars A; Halil MG
Support Care Cancer; 2022 Dec; 30(12):9975-9981. PubMed ID: 36357794
[TBL] [Abstract][Full Text] [Related]
9. Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study.
Farcet A; de Decker L; Pauly V; Rousseau F; Bergman H; Molines C; Retornaz F
PLoS One; 2016; 11(2):e0149732. PubMed ID: 26918947
[TBL] [Abstract][Full Text] [Related]
10. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy Toxicity in Older Adults Optimized by Geriatric Assessment and Intervention: A Non-Comparative Analysis.
Hamid M; Hannan M; Myo Oo N; Lynch P; Walsh DJ; Matthews T; Madden S; O'Connor M; Calvert P; Horgan AM
Curr Oncol; 2022 Aug; 29(9):6167-6176. PubMed ID: 36135053
[TBL] [Abstract][Full Text] [Related]
12. Association of frailty and chemotherapy-related adverse outcomes in geriatric patients with cancer: a pilot observational study in Taiwan.
Ho YW; Tang WR; Chen SY; Lee SH; Chen JS; Hung YS; Chou WC
Aging (Albany NY); 2021 Nov; 13(21):24192-24204. PubMed ID: 34747717
[TBL] [Abstract][Full Text] [Related]
13. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.
Mahmoud AM; Biello F; Maggiora PM; Bruna R; Burrafato G; Cappelli M; Varughese F; Martini V; Platini F; Deambrogi C; Patriarca A; Nicolosi M; Vachanaram AR; Pisani C; Ferrara E; Catania E; Azzolina D; Barone-Adesi F; Krengli M; Gaidano G; Gennari A
BMC Geriatr; 2021 May; 21(1):320. PubMed ID: 34011271
[TBL] [Abstract][Full Text] [Related]
15. Validation of a frailty index in older cancer patients with solid tumours.
McCarthy AL; Peel NM; Gillespie KM; Berry R; Walpole E; Yates P; Hubbard RE
BMC Cancer; 2018 Sep; 18(1):892. PubMed ID: 30217171
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy use in older adults with cancer with frailty: A young SIOG review paper.
Guven DC; Martinez-Cannon BA; Testa GD; Martins JC; Velasco RN; Kalsi T; Gomes F
J Geriatr Oncol; 2024 May; 15(4):101742. PubMed ID: 38472009
[TBL] [Abstract][Full Text] [Related]
17. Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.
Hamaker ME; Jonker JM; de Rooij SE; Vos AG; Smorenburg CH; van Munster BC
Lancet Oncol; 2012 Oct; 13(10):e437-44. PubMed ID: 23026829
[TBL] [Abstract][Full Text] [Related]
18. How representative are participants in geriatric oncology clinical trials? The case of the 5C RCT in geriatric oncology: A cross-sectional comparison to a geriatric oncology clinic.
Habib MH; Alibhai SMH; Puts M
J Geriatr Oncol; 2024 Mar; 15(2):101703. PubMed ID: 38228054
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
[TBL] [Abstract][Full Text] [Related]
20. Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial.
Pearce J; Swinson D; Cairns D; Nair S; Baxter M; Petty R; Seymour M; Hall P; Velikova G;
J Geriatr Oncol; 2022 Apr; 13(3):287-293. PubMed ID: 34955446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
